glp 1 smoking cessation GLP-1 RAs for May Mitigate Weight Gain GLP-1 receptor agonists and smoking

doi: 10.1080/21655979.2021.2012950

This reduction in weight is largely due to the medications effects on appetite regulation, insulin sensitivity, and slower gastric emptying 3,8

Efficacy: Semaglutide has superior reductions in HbA1c and body weight compared to other agents, while tirzepatide, a dual GLP-1/GIP receptor agonist, shows even greater efficacy but with higher rates of adverse events

Enhancing Patient Outcomes with GLP-1 Agonists Improving patient outcomes with the use of GLP-1 receptor agonists extends beyond merely selecting an appropriate medication

Wernicke encephalopathy presenting with dysphagia: A case report and systematic literature review

Directed in vitro myogenesis of human embryonic stem cells and their in vivo engraftment